Cadence Neuroscience

About Cadence Neuroscience

Cadence Neuroscience is dedicated to transforming the lives of individuals with drug-resistant epilepsy by developing a personalized neuromodulation system. Their mission is to provide a more effective, customizable treatment to dramatically reduce seizures, enabling patients to live more independent lives. The company collaborates closely with Mayo Clinic to advance epilepsy care.

Products & Services

Personalized Neuromodulation System:A therapy system designed to address unmet needs in epilepsy care, combining tested hardware with innovative software to reduce seizures in patients with drug-resistant epilepsy.

Specialties

Neuromodulation Technology Epilepsy Care Clinical Innovation Neuroscience Engineering

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 26000000 MR: - FA: 26 million FAN: 26000000	D: 2023-05-17 FD: 2023-05-17	8 investors

Series B Latest

2023-05-17

$26.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kent Leyde

CEO

D

Doug Sheffield

CSO

E

Erik Anderson

Senior Electrical Engineer

G

Glen Baker

Senior Software Architect

M

Michael Baum

Director of Engineering

M

Mike Bland

Director of Engineering

View 16 more team members with Pro

Unlock Full Team Directory

Recent News